plerixafor has been researched along with Autoimmune Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horuk, R; Pease, J | 1 |
| Chen, H; Poznansky, MC; Tannous, BA; Wang, J | 1 |
| Aboumrad, E; Madec, AM; Thivolet, C | 1 |
| Billiau, A; Bridger, G; De Clercq, E; Hatse, S; Henson, GW; Matthys, P; Schols, D; Vermeire, K; Wuyts, A | 1 |
1 review(s) available for plerixafor and Autoimmune Disease
| Article | Year |
|---|---|
CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Benzylamines; Cyclams; Drug Contamination; HIV Infections; Humans; Neoplasms; Primary Immunodeficiency Diseases; Receptors, CXCR4; Signal Transduction; Tumor Microenvironment; Warts | 2020 |
3 other study(ies) available for plerixafor and Autoimmune Disease
| Article | Year |
|---|---|
Chemokine receptor antagonists.
Topics: Animals; Autoimmune Diseases; Humans; Receptors, Chemokine | 2012 |
The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
Topics: Adoptive Transfer; Animals; Autoimmune Diseases; Benzylamines; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Cyclams; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Heterocyclic Compounds; Islets of Langerhans; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Th2 Cells | 2007 |
AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.
Topics: Animals; Arthritis, Experimental; Autoantigens; Autoimmune Diseases; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Collagen Type II; Cyclams; Extremities; Heterocyclic Compounds; Hypersensitivity, Delayed; Interferon-gamma; Macrophage-1 Antigen; Mice; Mice, Inbred DBA; Mice, Knockout; Receptors, CXCR4 | 2001 |